C-reactive Protein Testing Market (By Assay Type: Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others; By Detection Range: hs-CRP, Conventional CRP, cCRP; By Disease Area: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others; By End-use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global C-reactive Protein Testing Market, By Assay Type

7.1.  C-reactive Protein Testing Market, by Assay Type, 2021-2030

7.1.1.    Immunoturbidimetric Assay

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    ELISA

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Chemiluminescence Immunoassay

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global C-reactive Protein Testing Market, By Detection Range

8.1.  C-reactive Protein Testing Market, by Detection Range, 2021-2030

8.1.1.    hs-CRP

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Conventional CRP

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    cCRP

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global C-reactive Protein Testing Market, By Disease Area

9.1.  C-reactive Protein Testing Market, by Disease Area, 2021-2030

9.1.1.    Cardiovascular Diseases

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Cancer

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Rheumatoid Arthritis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Inflammatory Bowel Disease

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Endometriosis

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Lupus

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Others

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global C-reactive Protein Testing Market, By Capacitor

10.1.        C-reactive Protein Testing Market, by Capacitor, 2021-2030

10.1.1.  Clinics

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Hospitals

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Laboratories

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Assisted Living Healthcare Facilities

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Home

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Others

10.1.6.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global C-reactive Protein Testing Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

Chapter 12.  Company Profiles

12.1.              Thermo Fisher Scientific, inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              F. Hoffmann-La Roche Ltd.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Danaher

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Quest Diagnostics

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Siemens Healthineers AG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Abbott

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Merck KGaAA

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Zoetis

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Ortho Clinical Diagnostics

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Getein Biotech, Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           HORIBA, Ltd

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms